1.Clinical evidence of therapy of IgA nephropathy.
Wei-Hua GAN ; Ai-Qing ZHANG ; Gui-Xia DING ; Jing GONG
Chinese Journal of Contemporary Pediatrics 2007;9(2):101-103
Angiotensin-Converting Enzyme Inhibitors
;
therapeutic use
;
Anticoagulants
;
therapeutic use
;
Cyclophosphamide
;
therapeutic use
;
Cyclosporine
;
therapeutic use
;
Fish Oils
;
therapeutic use
;
Glomerulonephritis, IGA
;
therapy
;
Glucocorticoids
;
therapeutic use
;
Humans
;
Mycophenolic Acid
;
analogs & derivatives
;
therapeutic use
2.Application of microbiological and immunological enteral nutrition in patients with gastrointestinal cancer complicated with diabetes mellitus.
Feng SHAO ; Cheng-gang YANG ; Xin LIU ; Dao-gui YANG
Chinese Journal of Gastrointestinal Surgery 2012;15(5):476-479
OBJECTIVETo investigate the effects of microbiological and immunological enteral nutrition using composition of probiotics, glutamine, fish oil, and peptisorb on patients with gastrointestinal cancer complicated with diabetes mellitus.
METHODSFrom January 2007 to October 2010, 67 patients with gastrointestinal cancer complicated with diabetes mellitus were admitted to the Liaocheng People's Hospital of Shandong Province and were randomized into the treatment group(n=33, enteral nutrition with probiotics, glutamine, and fish oil) and the routine group(n=34, regular enteral nutrition). Fasting blood glucose(FBG), insulin(FINS), number of lymphocytes(including CD3(+)T cell, CD4(+)T cell, CD8(+)T cell, CD4(+)/CD8(+)) and natural killer (NK) cells of the two groups were detected on the day before surgery and postoperative day 3 and 7. Insulin resistance index (InHOMA-IR) was calculated by using the homeostasis model assessment(HOMA). The incidence of nosocomial infections and intestinal function recovery time, and length of hospital stay were collected.
RESULTSOn postoperative day 7, FINS[(8.4±3.7) mU/L vs. (13.7±5.4) mU/L, P<0.05] and InHOMA-IR(1.11±0.23 vs. 1.68±0.39, P<0.05) were lower in the treatment group than that in the routine group. The number of CD4(+)[(45.2±5.4)% vs. (38.1±2.9)%, P<0.05], CD4/CD8 (2.05±0.27 vs. 1.58±0.16, P<0.05), and NK cells [(19.5±6.6)% vs. (15.4±5.6)%, P<0.05] were higher in the treatment group. There were no significant differences in nosocomial infection [6.1%(2/33) vs. 17.6%(6/34), P>0.05] and intestinal function recovery time[(69.3±9.5) h vs. (70.1±11.6) h, P>0.05] between the two groups. However, the length of hospital stay [(17±3.8) d vs. (21±4.2) d, P<0.05] was significantly shorter in the treatment group.
CONCLUSIONFor patients with gastrointestinal cancer complicated with diabetes mellitus, microbiota enteral nutrition can reduce insulin resistance, improve the immune status, and promote postoperative recovery.
Adult ; Aged ; Diabetes Mellitus ; therapy ; Enteral Nutrition ; methods ; Female ; Fish Oils ; therapeutic use ; Gastrointestinal Neoplasms ; complications ; therapy ; Glutamine ; therapeutic use ; Humans ; Male ; Middle Aged ; Postoperative Care ; Probiotics ; therapeutic use
3.Application of a lipid emulsion for parenteral nutrition support in intensive care patients following gastrointestinal surgeries.
Dun PAN ; Hui CHEN ; Liangqing LI
Journal of Southern Medical University 2015;35(9):1312-1315
OBJECTIVETo investigate the effect of parenteral nutrition support with a lipid emulsion formulation (containing soybean oil, medium chain triglycerides, olive oil, and fish oil [SMOF]) in intensive care patients following major gastrointestinal surgeries.
METHODSAccording to a randomized, prospective and case-controlled design, 72 intensive care patients following major gastrointestinal surgeries between January and December, 2014 were randomized equally into SMOF group and control group to receive parenteral nutrition support with SMOF and medium or long chain lipid emulsion, respectively. Before and at 4 and 9 days after commencement of parenteral nutrition support, the patients were examined for alanine aminotransferase (ALT), total bilirubin (TBIL), albumin (propagated), C-reactive protein (CRP), interleukin 6 (IL-6), and endotoxin levels. The patients' average length of stay in intensive care unit (ICU), the days of using antibiotics, and the incidence rate of postoperative complication were recorded.
RESULTSOn day 4 postoperatively, the levels of CRP and IL-6 were significantly lower in SMOF group than in the control group (t=2.669 and 2.676, respectively; P<0.05), and on day 9, the patients in SMOF group showed significantly lower levels of ALT, TBIL, CRP and IL-6 (t=2.487, 3.497, 3.762, 2.180, respectively; P<0.05) than the control group, but ALB and endotoxin levels remained comparable between the two groups. The average length of stay in ICU and the days of using antibiotics were significantly shorter in SMOF group than in the control group (t=2.94 and 2.17, respectively; P<0.05); SMOF group showed a lower incidence of postoperative infections than the control group, but the difference was not statistically significant (χ² =1.047, P>0.05).
CONCLUSIONFor intensive care patients following major gastrointestinal surgeries, postoperative parenteral nutrition support with SMOF can effectively reduce the release of inflammatory mediators, protect important visceral functions, reduce postoperative complications, shorten the length of ICU stay, and improve the prognosis of the patients.
Alanine Transaminase ; blood ; Bilirubin ; blood ; C-Reactive Protein ; chemistry ; Critical Care ; Digestive System Surgical Procedures ; Fat Emulsions, Intravenous ; therapeutic use ; Fish Oils ; Humans ; Interleukin-6 ; blood ; Olive Oil ; Parenteral Nutrition ; Plant Oils ; Prospective Studies ; Soybean Oil ; Triglycerides
4.Use of fish oil lipid emulsion in patients undergoing major surgery and those with systemic inflammatory response syndrome: a cost-effectiveness analysis.
Jian GAO ; Chun-yan JI ; Guo-hao WU
Chinese Journal of Gastrointestinal Surgery 2012;15(5):452-456
OBJECTIVETo investigate the cost-effectiveness of fish oil in patients undergoing major surgery and those with systemic inflammatory response syndrome(SIRS).
METHODSA retrospective study was conducted in patients undergoing major surgery and those with SIRS on admission in the Zhongshan Hospital from January 2008 to December 2011. Fish oil group was enrolled and matched to control group by 1:2 for gender, age, diagnosis, and surgical procedure. There were 220 pairs of patients who were not admitted to ICU, 102 pairs of patients admitted to ICU, and 66 pairs of patients with SIRS. The clinical outcomes and costs were measured and cost-effectiveness analyses were conducted.
RESULTSThe clinical outcomes and costs showed no significant difference between the fish oil group and the control group in those patients who were not admitted to ICU(P>0.05). Fish oil fat emulsion supplementation significantly reduced the length of total hospital stay, postoperative hospital stay, ICU stay, re-operation rate, infection rates, perioperative mortality in patients admitted to ICU and those with SIRS(P<0.05). The cost-effectiveness ratio of non-reoperation rate, non-infection rate, and survival rate were lower in those patients receiving fish oil fat emulsion as compared with those without fish oil administration. Fish oil fat emulsion supplementation could reduce cost-effectiveness ratios of non-reoperation rate, non-infection rate and survival rate by 105 RMB, 160 RMB, and 89 RMB respectively in major surgical patients who admitted to ICU, and by 670 RMB, 280 RMB, and 220 RMB respectively in SIRS patients.
CONCLUSIONSAddition of fish oil fat emulsion to clinical nutrition may have positive effects on critically ill patients. It seems that the effects of fish oil fat are strongly related to the severity of patient's underlying disease. Fish oil fat emulsion supplementation shows acceptable cost-effectiveness ratio and pharmacoeconomic value.
Aged ; Cost-Benefit Analysis ; Fat Emulsions, Intravenous ; economics ; therapeutic use ; Female ; Fish Oils ; economics ; therapeutic use ; Humans ; Male ; Middle Aged ; Parenteral Nutrition ; economics ; methods ; Postoperative Care ; Retrospective Studies ; Surgical Procedures, Operative ; Systemic Inflammatory Response Syndrome ; therapy
5.Influence of Lipoplus fat emulsion on postoperative nutritional status and early inflammatory response in patients with gastrointestinal malignancies.
Cai-hua ZHANG ; Ning LI ; Xin-ying WANG ; Guo-li LI ; Chao-gang FAN ; Jie-shou LI
Chinese Journal of Gastrointestinal Surgery 2012;15(5):448-451
OBJECTIVETo investigate the effect of Lipoplus on postoperative nutritional status and inflammatory response in patients with gastrointestinal malignancies.
METHODSSixty-four patients with gastrointestinal malignancies were randomized using random digit table to receive isonitrogenous, isocaloric total parenteral nutrition for 5 days including either Lipoplus or Lipofundin with 32 patients in each group. Blood samples were obtained before the surgery, postoperative days 1, 2, 3, and 6 to evaluate the nutritional status(prealbumin, retinol binding protein, and nitrogen balance) and inflammatory response [C-reaction protein(CRP), and leukotriene(LTB) 5, LTB4]. The incidence of postoperative systemic inflammatory response syndrome(SIRS), infection, postoperative complications, mortality, APACHEII score, length of hospital stay and other clinical indicators were recorded.
RESULTSOn postoperative day 1, prealbumin and retinol binding protein were significantly lower as compared to preoperative levels. These parameters increased significantly(P<0.05) on postoperative day 6 and the nitrogen balance was positive. On postoperative day 6, CRP was significantly lower in both groups as compared to postoperative day 3 (P<0.05), and the decrease was more prominent in Lipoplus than Lipofundin(P<0.05). There was a significant increase in LTB5/LTB4 as compared to postoperative day 1(P<0.05) in the Lipoplus group, however the increase was not statistically significant in the Lipofundin group(P>0.05). The incidence of postoperative infection was significantly lower in the Lipoplus group(3.1% vs. 6.3%, P<0.05), as was that of SIRS(9.4% vs. 15.6%, P<0.05). The APACHEII score was higher in the Lipoplus group but the difference was not statistically significant(3.6±2.0 vs. 3.3±2.1, P>0.05). The length of hospital stay was significantly shorter in Lipoplus group[(6.4±1.1) d vs. (8.2±1.3) d, P<0.05].
CONCLUSIONLipoplus can improve the postoperative nutritional status and minimize the inflammatory response in patients with gastrointestinal malignancies.
Adult ; Aged ; Digestive System Surgical Procedures ; Fat Emulsions, Intravenous ; administration & dosage ; therapeutic use ; Female ; Fish Oils ; administration & dosage ; therapeutic use ; Gastrointestinal Neoplasms ; surgery ; Humans ; Inflammation ; therapy ; Male ; Middle Aged ; Nutritional Status ; Parenteral Nutrition, Total ; methods ; Postoperative Care
6.Effect of omega-3 fish oil fat emulsion on the peripheral neuropathy caused by bortezomib.
Xing-xing LONG ; Ya GAO ; Bao-hong PING
Chinese Journal of Hematology 2011;32(9):633-634
Boronic Acids
;
adverse effects
;
Bortezomib
;
Fatty Acids, Omega-3
;
administration & dosage
;
therapeutic use
;
Fish Oils
;
administration & dosage
;
therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Peripheral Nervous System Diseases
;
chemically induced
;
drug therapy
;
Pyrazines
;
adverse effects
7.Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery.
Ming-Wei ZHU ; Da-Nian TANG ; Jing HOU ; Jun-Min WEI ; Bin HUA ; Jian-Hua SUN ; Hong-Yuan CUI
Chinese Medical Journal 2012;125(2):178-181
BACKGROUNDPolyunsaturated omega-3 fatty acids may beneficially influence healing processes and patient outcomes. The aim of this research was to study the clinical efficacy of fish oil enriched total parenteral nutrition in elderly patients after colorectal cancer surgery.
METHODSFifty-seven elderly patients with colorectal cancer were enrolled in this prospective, randomized, double-blind, controlled clinical trial. All patients received isocaloric and isonitrogenous total parenteral nutrition by continuous infusion (20 - 24 hours per day) for seven days after surgery. The control group (n = 28) received 1.2 g/kg soybean oil per day, whereas the treatment group (n = 29) received 0.2 g/kg fish oil and 1.0 g/kg soybean oil per day. Blood samples were taken pre-operatively, and at days one and eight after the operation. The plasma levels of CD4, CD8, CD4/CD8, interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) were measured. Clinical outcomes were then analysed.
RESULTSPatient characteristics were comparable between the two groups. At day eight post-surgery, IL-6, TNF-α and CD8 titres were lower in the treatment group when compared to the control group; these results reached statistical significance. In the treatment group, there were fewer infectious complications and incidences of systemic inflammatory response syndrome (SIRS), and shorter lengths of hospital stay were observed. The total cost of medical care was comparable for the two groups. No serious adverse events occurred in either group.
CONCLUSIONSFish oil 0.2 g/kg per day administrated to elderly patients after colorectal surgery was safe and may shorten the length of hospital stay and improve clinical outcomes.
Aged ; CD4 Antigens ; blood ; CD4-CD8 Ratio ; CD8 Antigens ; blood ; Colorectal Neoplasms ; blood ; surgery ; Colorectal Surgery ; Female ; Fish Oils ; therapeutic use ; Humans ; Interleukin-6 ; blood ; Male ; Middle Aged ; Parenteral Nutrition, Total ; methods ; Tumor Necrosis Factor-alpha ; blood
8.Validation of the Oxford Classification of IgA Nephropathy: A Single-Center Study in Korean Adults.
Hoyoung LEE ; Sul Hee YI ; Mi Seon SEO ; Jin Nam HYUN ; Jin Seok JEON ; Hyunjin NOH ; Dong Cheol HAN ; Seung Duk HWANG ; So Young JIN ; Soon Hyo KWON
The Korean Journal of Internal Medicine 2012;27(3):293-300
BACKGROUND/AIMS: The recently published Oxford classification of IgA nephropathy (IgAN) proposed a split system for histological grading, based on prognostic pathological features. This new classification system must be validated in a variety of cohorts. We investigated whether these pathological features were applicable to an adult Korean population. METHODS: In total, 69 adult Korean patients with IgAN were analyzed using the Oxford classification system at Soonchunhyang University Hospital, Seoul, Korea. All cases were categorized according to Lee's classification. Renal biopsies from all patients were scored by a pathologist who was blinded to the clinical data for pathological variables. Inclusion criteria were age greater than 18 years and at least 36 months of follow-up. We excluded cases with secondary IgAN, diabetic nephropathy combined other glomerulopathies, less than 36 months of follow-up, and those that progressed rapidly. RESULTS: The median age of the patients was 34 years (range, 27 to 45). Mean arterial blood pressure was 97 +/- 10 mmHg at the time of biopsy. The median follow-up period was 85 months (range, 60 to 114). Kaplan-Meier analysis showed significant prognostic predictions for M, E, and T lesions. A Cox proportional hazard regression analysis also revealed prognostic predictions for E and T lesions. CONCLUSIONS: Using the Oxford classification in IgAN, E, and T lesions predicted renal outcome in Korean adults after taking clinical variables into account.
Adult
;
*Asian Continental Ancestry Group
;
Biopsy
;
Chi-Square Distribution
;
Disease Progression
;
Female
;
Fish Oils/therapeutic use
;
Glomerulonephritis, IGA/classification/*diagnosis/ethnology/pathology/therapy
;
Hospitals, University
;
Humans
;
Immunosuppressive Agents/therapeutic use
;
Kaplan-Meier Estimate
;
Kidney/*pathology
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Predictive Value of Tests
;
Prognosis
;
Proportional Hazards Models
;
Reproducibility of Results
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Severity of Illness Index
;
Time Factors